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ABSTRACT
THE EXTRACTION OF TYPE I COLLAGEN AND THE FABRICATION
OF MULTI-FILAMENT EMBEDDED HYDROGELS FOR GUIDED
NERVE REGENERATION
by
Mevan Lakmal Siriwardane
Each year, there are approximately 11,000 new cases of spinal cord injury (SCI) in the
United States [2]. There have been some success in pre-clinical studies to induce axonal
generation, but the reconnection of axons over large distances remains the greatest
challenge. Since the development of nerve conduit to facilitate general axonal
regeneration, the primary focus has changed to directing the regeneration of axons while
also promoting their outgrowth over very extensive lesions to ensure functional recovery
of transected nerves during in vitro experiments by using natural materials such as type I
collagen, which is the largest constituent of the extra-cellular matrix of living tissue. In
this project, fabrication of novel constructs for nerve tissue guidance was carried out
using homogenous hydrogels and multi-filament arrays of wet-spun fibers/hydrogel
composites derived from extracted type I collagen. A comparison of axonal outgrowth
on 2D and 3D environments revealed that dorsal root ganglia (DRGs) slightly favored 3D
collagen gels compared to 2D collagen substrates after 9 days of culture. DRG neurites
grown on 3D collagen gels exhibited optimal growth on a 0.8 mg/ml collagen gel
concentration.
Extracted type I bovine collagen was wet spun at 2% and 5% wt bovine collagen
in ethanol to yield fibers as small as 1.389 in diameter. BCA total protein assay and
SDS-PAGE were used to validate the quantity and purity of extracted rat tail collagen.
Doublet bands present at 235 kDa and 215 kDa and another pair of doublets at 130 kDa

and 115 kDa characteristic of rat tail type I collagen were seen for both extracted and
commercial rat tail collagen using SDS-PAGE. Low absorbance values from BCA total
protein revealed that this technique is not suitable for quantifying rat tail type I collagen.
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CHAPTER 1
INTRODUCTION

1.1 Motivation
In recent years, there has been tremendous progress in understanding the interactions
between biological tissue and materials. The advancements in the emerging field of tissue
engineering have offered many therapeutic treatments and new methods in regenerative
medicine. However, the progress of tissue engineering approaches in nerve regeneration
has been slow and there is much more to be learned about the mechanisms in which
various natural and synthetic biomaterials interact with regenerating nervous tissue.
Although a few preclinical studies have shown promising techniques that enhance axon
outgrowth in animal models of spinal cord injury (SCI), the greatest challenge to
overcome is to produce axons of sufficient length and number to completely bridge the
extensive lesions seen in SCI.
Approximately 10,000 patients suffering from SCI and another estimated 250,000
have to endure devastating disabilities from chronic SCI each year in the U.S. due to
limited techniques available in repairing nerve tissue damage and clinically effective
approaches to treat spinal cord lesions [5]. In order to establish effective axon guidance
treatments for nerve tissue regeneration, it is desirable to create a nerve conduit for
animal studies that naturally mimic the morphology and function of natural axon
fascicles. Since type I collagen is a natural component present in most biological tissues,
it selected as the central component of the nerve conduit consisting of hydrogel and wetspun fibers in this study. Type I collagen extracted from bovine tendon was wet-spun into
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fibers with varying fiber diameters to serve as an extra-cellular matrix (ECM) component
of a guided nerve conduit for potentially regenerating dorsal root ganglia axons.

1.2 Background Information: Spinal Cord Injury
Spinal cord injury (SCI) is a severely devastating disorder of the central nervous system
(CNS) and often results in the loss of function below the site of injury. In recent decades,
more than 60% of spinal cord injuries occurred in patients 15 to 30 years of age, who
have still many productive years ahead of them [2]. These injuries to a younger
generation of the population impose an enormous healthcare and economic burden on the
society. A sudden impact on the spinal cord induces a primary injury site, which consists
of severed axons, dying neurons and glia, and a disturbed microvasculature [1]. This
primary injury triggers a series of pathological events known as secondary damage
mechanisms, which often include vascular and biochemical changes, hemorrhagic
necrosis, inflammatory processes and delayed demyelination [1]. These secondary injury
mechanisms eventually lead to an extended primary lesion area, which is characteristic of
spinal cord injury. Unlike peripheral nerves, the central neuronal pathways of the spinal
cord consist of non-regenerating nerve cells that are unable to spontaneously restore
synaptic connections. As a result, functional recovery is virtually impossible.
Furthermore, dying and degenerating neurons cannot be replaced by new neurons. This
cascade of dynamic events results in glial scar tissue proliferation leading to permanent
loss of neuronal function and degradation of spinal nerves.
After the initial impact to the spinal cord, these pathological events significantly
hinder signal conduction, which is the transmission of action potentials along the length
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of axons. This disturbance in signal conduction leads to eventual impairment or loss of
body functions, which become mostly permanent. Severed ends of neurons make initial
attempts to re-grow but usually fail due to lack of guidance and loss of signal conduction
upon injury. Signal conduction can be restored only if regenerating axons reconnect
spinal cord circuits. If there is restoration of signal conduction, then the process of
functional recovery can be initiated. The restoration of signal conduction is primarily
achieved by the regeneration of severed axons and/or the formation of alternative neural
pathways. The formation of new nervous system pathways can occur by either, 1)
reconnecting severed axons with original target site or 2) establishing an alternate
connection with a new site functionally linked to the original target (i.e., wiring around
the lesion) [1].
The recapitulation and restoration of neuronal functionality of severed axons
occur at a very slow rate due to the hostile environment at the injured lesion site often
impeding any chance of central nervous system (CNS) axon re-growth. Severed axon
tracts, which are unable to reestablish functional relays, eventually undergo rapid
degeneration resulting in permanent loss of neural function. The key factors that seem to
act as barriers to axon regeneration are the relative lack of growth promoting factors,
presence of growth inhibitory molecules due to inflammatory response, alterations in
surrounding extracellular matrix (ECM) vasculature, and the formation of fibroglial scar
tissue along with cystic cavities [1]. In this study, the fabrication of a novel nerve
conduit will establish the facilitation of spinal axon regeneration by serving as a
protective shield from the hostile environment at the injury site.
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1.3 Physiology of the Nervous System

A thorough understanding of the physiology of the nervous system is crucial in
addressing the challenges of bioengineering research in treating nerve tissue injuries.
The application of biomaterials and engineering methodologies in nerve tissue repair
requires a broad knowledge of the general organization and the cellular components of
the nervous system including the anatomy of the peripheral nerves and the spinal cord.
Organization of the Nervous System. The nervous system is classified into the central
nervous system (CNS) and the peripheral nervous system (PNS). The CNS consists of
the brain, spinal cord, optic, and olfactory and auditory systems. Many of the functions
of the CNS include conducting and interpreting signals in addition to interfacing with the
PNS via excitatory stimuli. The PNS consists of cranial nerves from the brain, the spinal
nerves from the spinal cord, and the sensory nerve cell bodies (dorsal root ganglia) and
their processes. Peripheral nerves innervate muscle tissue, transmitting both sensory and
excitatory input to and from the spinal column. In this project, fetal rat dorsal root ganglia
were chosen to investigate two- and three-dimensional axonal outgrowth using nerve
conduit components made of type I collagen biomaterials.
Cellular Components of the Nervous System. The nervous system is composed of two
primary cell types: neurons and neuroglia. Neurons are the basic structural and
functional elements of the nervous system and consist of a cell body (soma) and its
extensions (axons and dendrites). In this study, the axons and their
outgrowth/regeneration behavior is the primary focus. Clusters of sensory nerve soma,
known as ganglia, are located just outside the spinal column. While dendrites transmit
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electrical signals to the neuron cell body, the axon conducts impulses away and to other
neighboring neurons with dendrite receptors. Glial cells, or neuroglia, are supporting cells
that aid the function of neurons and are present in both PNS and CNS. Neuroglia include
Schwann cells in the PNS and astrocytes and oligodendrocytes in the CNS. The
formation of glial scar tissue caused by the accumulation of astrocytes and
oligodendroctyes during SCI or other CNS injuries provides a hostile environment for the
regenerating axons. Glial cells, unlike neurons, are more abundant and exhibit some
capacity for cell division. Although neurons cannot divide by mitosis, they can regenerate
a severed portion or sprout new neural branches under certain limited conditions.
In the PNS, sheaths of living Schwann cells surround all axons. On the outer
surface of this inner Schwann cell layer is the neurilemma, which is a basement
membrane similar to that found in epithelial layers. Unlike the axons in the PNS, CNS
axons do not have this continuous protective basement membrane and sheath of Schwann
cells. Many axons in the CNS are only surrounded by an insulating myelin sheath, which
is formed from dense layers of successive wrappings of oligodendrocytes. Myelin serves
to increase the propagation velocity of the nerve impulse, which becomes especially
important for axons with extensive lengths (up to 1 m).
Anatomy of the Peripheral Nerve and Spinal Cord. In the context of designing nerve
conduits for facilitating guided nerve regeneration, a firm background knowledge of
peripheral nerve and spinal cord anatomy is essential. A peripheral nerve consists of
motor and sensory axons bundled together by support tissue into an anatomically defined
nerve trunk exhibiting a hierarchical level of structural organization (Figure 1.1). The
perineurium, which is formed from many layers of flattened cells and collagen, surrounds
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groups ofaxons to form bundle-like fascicles. The epineurium is the outermost sheath of
loose fibrocollagenous tissue, and it binds individual nerve fascicles into a nerve trunk.
Peripheral nerves are well vascularized by capillaries within the support tissue of the
nerve trunk or by vessels that penetrate the nerve from surrounding arteries and veins. A
thin encapsulating layer called an endoneurium surrounds individual axons and their
Schwann cell sheaths and is mainly composed of oriented collagen fibers. Therefore,
type I collagen was selected during this study to fabricate nerve conduit materials
consisting of collagen gels and wet-spun collagen fibers as the main structural
component.

Epineurium

Figure 1.1 Anatomical structure of the PNS [4].

The spinal cord is composed of dendrites, axons, and cell bodies (Figure 2). In the
center of the spinal cord is a butterfly-shaped region referred to as gray matter, which
contains the cell bodies of excitatory neurons including glial cells and blood vessels.
The gray matter is surrounded by white matter, which helps to protect and insulate
the spinal cord.

White matter consists ofaxons and glial cells, including
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oligodendrocytes, astrocytes, and microglia (immune cells).

In the CNS, the

oligodendrocytes serve to myelinate the axons in the CNS while the astrocytes contribute
to the blood-nerve barrier, which separates the CNS from blood proteins and cells. Axons
project from the white matter in bundles, known as fascicles, which extend to the
encasing bone of the spinal column, travel through the PNS-CNS transition zone, and
enter the PNS.
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Figure 1.2 Anatomy overview of the spinal cord. (a) Spinal cord consists of the cervical,
thoracic, lumbar, sacral, and coccygeal spinal regions. (b) Nerves are well protected by
vertebrae and protective membranes. (c) The nerves on left and right side are subdivided
into roots.

1.4 Nerve Injury and Regeneration

Peripheral Nervous System. The most severe injury to the PNS is a complete nerve
transection. After a nerve is severed, the distal portion begins to degenerate as a result of
disrupted protein transport and separation from the metabolic resources of the nerve cell
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bodies. The cytoskeleton begins to breakdown, followed by the dissolution of the cell
membrane. The proximal end of the nerve stump swells, but experiences only minimal
damage via retrograde degradation. During the onset of cytoskeleton and membrane
degradation, Schwann cells surrounding the axons in the distal end shed their myelin
lipids. Phagocytotic cells, such as macrophages and Schwann cells, clear myelin and
axonal debris. In addition to clearing myelin debris, macrophages and Schwann cells also
produce cytokines, which enhance axon growth. Following debris clearance, regeneration
begins at the proximal end and continues toward the distal stump. New axonal sprouts
usually emanate from the nodes of Ranvier, nonmyelinated areas of axons located
between Schwann cells. Functional reinnervation requires that axons extend until they
reach their distal target, and in humans, axon regeneration occurs at a rate of about 2-5
mm/day. As a result, significant injuries can take several months to heal.
Central Nervous System. A key difference between the PNS and CNS is the capacity for
peripheral nerves to regenerate unlike CNS axons, which do not regenerate appreciably in
their native environment. Several glycoproteins in the native extra-cellular environment
(myelin) of the CNS are inhibitory for regeneration. The physiological response to injury
in the CNS is also different compared to that of the PNS. After injury in the CNS,
macrophages infiltrate the site of injury much more slowly compared to macrophage
infiltration in the PNS, delaying the removal of inhibitory myelin. This is largely a result
of the blood-spine barrier, which limits macrophage entry into the nerve tissue to just the
site of injury, where barrier integrity is weakened. In addition, cell adhesion molecules in
the distal end of the injured spinal cord are not upregulated appreciably as they are in the
PNS, limiting macrophage recruitment. Finally, astrocytes proliferate in a manner similar
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to that of Schwann cells in the PNS, but instead become "reactive astrocytes," producing
glial scar tissue that inhibits regeneration.

1.5 Collagen Overview

The collagens comprise of a family of fibrous proteins found in all multicellular animals.
Since collagen is biodegradable, biocompatible, and nonimmunogenic, it is a desirable
material for a variety of biomedical applications. Collagen is the most abundant protein in
the tissues of vertebrates and is present in at least ten different forms, each of which is
dominant in specific tissue. As one of the major components of the extra-cellular matrix
(ECM), collagen is well known to promote cellular proliferation and tissue healing. The
commonality among all the types of collagen is the characteristic triple helix, which
consists of three left-handed a-helices wound into a right-handed triple helix (Figure 3).
Each individual a-helix chain contains one or more polypeptide sequences (Gly-X-Y), in
which X and Y positions are frequently occupied by proline and hydroxypro line residues,
respectively.
_ ----14\

Figure 1.3 Collagen triple helix
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Glycine constitutes about one-third of all residues while proline and hydroxyproline
make up about 13% and 10%, respectively. The variations within this triple helix are
limited to the length of the helix and the number of carbohydrate attachments on the
triple helix contributing to all the different structural types of collagen. The different achains that constitute the collagen triple helix associate with each other in the following
manner:
1) Hydrogen bonding between the NH group of glycines and
the CO group from residues of the other a-chains.
2) Hydrogen bonding among OH groups of hydroxyprolines.
3) Hydrogen bonding with water molecules.

These bonds are essential for stabilizing the triple-helical structure of collagen.
The repulsion from proline residues is the key factor in contributing to the helical
structure and turns the H-side chain of the glycines to the inside of the helix. All the
bulky side chains point to the outside of the collagen triple helix due to the lack of space
inside the helix. In general, glycines, prolines, and hydroxyprolines are the primary
residues responsible for maintaining the triple helix structure while the remaining amino
acid residues play key roles in higher order structural regularities. The amino acid
residues 4- and 3-hydroxyproline and 5-hydroxylysine are almost exclusively found in
collagen and are vital for interchain linking with hydrogen bonds for stability of the
helical structure. As a result, the stability of the collagen triple helix strongly depends on
the delicate proportion of prolines and hydroxyprolines.
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The structure of the a-helix chains is often used to classify collagen into fibrillar
and nonfibrillar forms. The fibrillar collagens comprise of types I, II, III, V, and XI.
These collagen types form distinct cross-striated fibrils, and all share a triple helical
region containing approximately 1,000 amino acids per chain, which has a length of
about 300 nm. These different structural forms of collagen contribute to their varying
composition from one tissue to another. The structural nature of type I collagen enables
it to form fibrils unlike some of the other nonfibrillar types of collagen. As a result, type
I collagen is found in tissues such as skin, tendon, ligaments, and bone where mechanical
strength and tensegrity are important factors in tissue function. While type I collagen is
the primary constituent that makes up the extra-cellular matrix (ECM) of most biological
tissue, it is also broadly used for supporting nerve growth. Therefore, type I collagen
was the material of choice for this experiment.
There are various sources that can be used to extract type I collagen. The main
sources of collagen for commercial applications are bovine tendons, calf, or pig hide. In
general reconstituted collagen products are prepared in vitro by purification of native
collagen by enzyme treatment and chemical extraction. Once the collagen is purified, it
can be dispersed or dissolved in solution, filtered, and retained. Furthermore, purified
collagen can also be reconstituted into fiber, film, or sponge form through extrusion,
casting, or lyophilization techniques.
In this study, dialysis procedures were performed on the material as part of the
extraction process to assure purity while the final form of the material was reached only
after lyophilization. Type I collagen was extracted from two sources: rat tail tendon and
bovine tendon. In the case of rat tail collagen, the end product was a sponge-like material
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with the use of lyophilization. Since bovine samples are the most readily available and
generate a huge yield per tendon, they are the most ideal to use as a source of type I
collagen. The end product following lyophilization of bovine collagen was interwoven
fibrous string-like material. In this study, dorsal root ganglia (DRG) neurite outgrowth
behavior on rat tail and bovine type I collagen was investigated. A SDS-Page was used
to identify the level of purity of the type I collagen and to check for any other protein
contamination.

1.6 Challenges and Bioengineering Strategies for Nerve Repair
Although there have been tremendous progress in nerve repair therapies such as the nerve
graft, there still remains a strong demand for more clinically approved therapies. In the
PNS, an alternate approach to autologous nerve grafts is desired. Some alternative
treatments that have been developed in the recent years include nerve guidance channels,
especially for more extensive lesions. In the CNS, there are greater challenges
encountered for developing new therapies. Research in the area of spinal cord injury
(SCI) remained stagnant until a 1980 study revealed that spinal nerves were able to
regenerate [4]. In some studies, embryonic spinal cord grafts and peripheral nerve tissue
grafts have been shown to support regenerating axons in the CNS but with limited
success in guiding them to specific targets [4]. Therefore, many bioengineering efforts
are focused on creating a permissive environment for regeneration while providing a
means of guiding regenerating axons to establish functional recovery with the damaged
nerve ends. Many researchers are currently focusing on efforts to create physical or
chemical pathways for regenerating axons. Some latest approaches include physical or
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mechanical guidance cues, cellular components, and biomolecular signals. Perhaps,
future therapies will incorporate multiple cues in an integrated bioreactor device that
more closely mimics native tissue.

CHAPTER 2
CURRENT TECHNIQUES FOR NERVE REPAIR
2.1 Autologous Tissue Grafts
For several decades, autologous tissue grafts have been the gold standard for repair of a
peripheral nerve defect. Since they are natural materials, autologous tissue grafts possess
several advantages and are more likely to be biocompatible compared to synthetic,
artificial materials. In addition, they have been shown to be less toxic and provide a
suitable support structure to promote cell adhesion and migration. The potential
difficulties that arise with autografts include isolation and controlled scale-up [4].
In recent years, autologous tissue grafts have been used extensively for nerve repair
applications. The sources of nerve autografts are typically derived from one of several
cutaneous nerves, such as the sural or saphenous nerve. These nerves have an available
length up to approximately 40 cm and a cable diameter of 2-3 cm [4]. For peripheral
nerve injury, treatment typically consists of either direct end-to-end surgical reconnection
of the damaged nerve ends (Figure 3) by the use of an autologous nerve graft. However,
suturing the two nerve ends together can only repair small defects or gaps in the nerve.
For longer nerve gaps, this approach is not desired because any tension introduced into
the nerve cable would inhibit nerve regeneration.
In addition to the autologous nerve graft, other natural tissues such as autologous
muscle and vein grafts have been employed but with limited clinical success. In terms of
peripheral nerve repair, epineurial sheaths, tendon grafts, muscle-vein grafts, and vein
grafts impregnated with autologous Schwann cells are just a few examples of the research
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efforts focused on natural tissue grafts.

Figure 2.1 Surgical end-to-end reconnect ion [4].

Despite the encouraging results in research, there still remams a series of
drawbacks to using autologous tissue grafts. Since an autologous nerve graft must be
harvested from another site in the body and then used to span the injury site, this
approach is not practical for a larger nerve defect.

In addition, there are many

disadvantages to using autologous nerve grafts such as loss of function at the donor site
and the need for multiple follow-up surgeries [4].

2.2 Nonautologous Tissue and Acellular Grafts

Since there have been many limitations with using autologous tissue as nerve grafts, the
use of nonautologous tissue and extracellular matrix (ECM)-based materials have become
the focus of intense research.

Allogenic and xenogenic tissues (donor tissue from

cadavers and animals, respectively) provide many benefits such as an abundant supply
while not having to harvest tissue from the patient. Nevertheless, tissues from these
sources exhibit a potential risk for transmitting disease and eliciting an immune response.
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In order for these tissues to be biocompatible for nerve conduit applications, they must be
used in conjunction with immunosuppressants or they must be acellular (immunogenic
components and cells removed).
The decellularization of tissue is considered effective when all immunogenic
cellular components are removed while leaving the structure of the ECM well intact.
Some techniques used to decellularize nonautologous tissue include thermal
decellularization, which involves repeated freeze-thaw cycles to kill and fragment cells.
Although this technique appears to be effective in minimizing immune response, there is
no guarantee that all cellular remnants are completely removed. Radiation treatments are
also used to destroy cells in tissues but also fail to extract all cellular components.
Although acellular tissues for clinical nerve repair may be a viable option in the future,
better decellularization techniques are needed.
Some other natural nonautologous tissues investigated for neural tissue engineering
applications include small intestinal submucosa (SIS) and amniotic tissue grafts [4]. SIS
is extracted from the mucosa and muscle layers of the small intestine, which are rinsed in
hypotonic solution to lyse and wash away cells. Once SIS is processed, the resulting
ECM material consists of collagen, fibronectin, growth factors, glycosaminoglycans
(GAGs), proteoglycans, and glycoproteins, which are all conducive to cell adhesion, cell
growth, and cell differentiation [4]. Therefore, SIS tissue grafts may be a potential
alternative to nerve autografts. Amnion obtained from human placental tissues has also
been heavily explored for its potential use in nerve regeneration applications. Amnion
tissue is processed by the removal of the epithelial cell layer while preserving the
structural integrity of the basement membrane and stromal surfaces. The resulting
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acellular amnion tubes may demonstrate potential for nerve regeneration given further
studies to validate its application as a nerve conduit.

2.3 Natural Based Materials
-

Besides using intact ECM acellular tissues, there have been tremendous research interests
in the use of purified natural ECM proteins, proteoglycans, and glycosaminoglycans,
which can be modified to serve as appropriate scaffolding for nerve repair and
regeneration. Many studies have revealed that ECM molecules such as laminin, collagen,
and fibronectin play significant roles in neuron adhesion, axonal development, and nerve
repair in the body [9, 16-18]. Many of these ECM component molecules provide
chemical and physical cues, which are factors that can modulate neural activity and
enhance neurite outgrowth. ECM proteins laminin, fibronectin, and collagen have been
used as coatings, filaments, matrices, and hollow tube conduits in numerous nerve repair
applications [9-12, 14, 16-18]. In other studies, collagen tubes containing a porous
collagen-glycosaminoglycan matrix have demonstrated nerve regeneration rates
comparable to nerve autografts [4].
In addition to ECM molecules, other naturally derived molecules that have been
studied include fibrinogen, hyaluronic acid, fibrin gels, self-assembling peptide scaffolds,
agarose, alginate, and chitosan. The research focus in many latest studies is to further
modify these materials through photolithographic patterning techniques or by combining
them with other bioactive molecules or growth factors to further enhance neurite
extension. Although there have been many experimental successes with these natural
materials, very few approaches have been clinically approved.
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2.4 Synthetic-Based Materials
Many synthetic materials have also been investigated for nerve repair applications. There
are many advantages to using synthetic materials because their chemical and physical
properties (i.e., mechanical strength, porosity, degradation rate) can be specifically
optimized for any given application. Synthetic materials pose challenges in biomedical
applications because the body's inflammatory response can vary considerably from one
material to another. In some cases, certain synthetic materials are tolerated by the body's
immune system but are incompatible with cell adhesion and tissue repair.
The choice of a synthetic material should be heavily evaluated to ensure the
material meets specific criteria for the intended biomedical application. Synthetic
materials that are intended for nerve repair applications should possess the following
desired properties:
• Easily shaped and formed to desired dimensions
• Sterilizable
• Biodegradable
• Non-toxic/Nonimmunogenic
Synthetic materials that remain permanent are more inclined to provoke a chronic
inflammatory response. Nerve guide conduits with materials that degrade as the nerve
regenerates are most desirable. A number of different synthetic materials have been
explored for use in aiding nerve regeneration such as poly(glycolic acid) (PGA),
poly(lactic acid) (PLA), and poly(lactic-co-glycolic acid) (PLGA). They are classified as
poly(esters) and have been processed as foams or scaffolds or seeding with Schwann
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cells to enhance regenerative potential in several studies. These materials continue to be
studied and further modified for nerve repair applications due to their availability, ease of
processing, biodegradation characteristics, and FDA approval.
Many studies have also used nondegradable synthetic materials such as silicone
for nerve conduits. Although silicone tubes can be used to bridge short gaps with some
success, they do not support regeneration across defects larger than 10 mm unless growth
factors are incorporated [4]. Furthermore, the impermeable and inert properties of
silicone tubes limit their application as nerve conduits. As a result, a great deal of
research is now focused on developing semipermeable or degradable guidance channels
that can facilitate regeneration over more extensive lesions.
Poly(ethylene glycol) (PEG) has also been applied to nerve regeneration
applications. In one study, PEG was the material of choice for fusing the membranes of
severed nerve ends from sciatic and spinal nerves [4]. However, the limitation of this
approach is that it can only be applied for small nerve defects in which the severed nerve
ends are directly adjacent to each other. Other efforts have focused on using cross-linked
PEG hydrogels that are modified with factors to mimic the ECM [4].

2.5 Cellular-Based Therapies
Nerve regeneration can be facilitated by the application of vital biomolecules such as
supportive ECM components, neurotrophic factors, and cell adhesion molecules. Cells
are essential in any tissue engineering or reparative medicine approach since they are
carriers and producers of many of these vital biomolecules. Glial cells such as Schwann
cells, astrocytes, and oligodendrocytes along with other cells like macrophages support
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nerve tissue regeneration by clearing debris and secreting neurotrophic factors to aid
axonal outgrowth [4]. Some other cells including stem cells and genetically modified
cells have been intensely studied as grafts for supporting nerve regeneration.
Schwann cells, which are one of many types of glial cells are primarily responsible
for the supportive environment within nerve tissue since they produce the extra-cellular
matrix (ECM), cell adhesion molecules, integrins, and neurotrophins. Schwann cells are
also intensely studied for nerve regeneration because they are known to play a critical
role in leading peripheral axons to the distal nerve stump. A series of studies of Schwann
cells in central and peripheral nerve injuries have primarily focused on techniques to
deliver these cells to the injury site [4]. However, there are several challenges facing
Schwann cell therapies for spinal cord repair. Regenerating axons that grow into
Schwann cell grafts often fail to leave this favorable environment due to harsh
interactions with components in glial scar tissue. Furthermore, Schwann cells have not
been found to remyelinate axons beyond the injury site and may actually increase
chondroitin sulfate proteoglycan, which is a non-permissive component of glial scar.
Although Schwann cells have been associated with some success in promoting spinal
cord repair, they may show more promise when combined with other treatments
Glial cells such as astrocytes, oligodendrocytes, and microglia as cell-based
therapies still remain to be well understood. There may be limitations in using CNS glial
cells since they are capable of contributing to the formation of glial scar tissue, which is
inhibitory toward axonal growth. Therefore, a greater understanding of CNS glia must be
obtained before dependable therapies can be implemented for spinal cord repair.
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Macrophages, like Schwann cells, play a vital role in promoting peripheral nerve
repair by removing myelin debris. Therefore, many researchers have transplanted
macrophages into peripheral nerve and spinal cord injuries [4]. Macrophage-based
transplants have been associated with a significant decrease in myelin-associated
glycoproteins while increasing axonal regeneration. Although macrophages are known to
clear myelin debris at a nerve injury site, other means by which they aid in regeneration
remains unclear.
Many researchers have recently investigated the potential of stem cells in nerve
regeneration applications. Neural stem cells have been isolated from rodent brain, spinal
cord, skeletal muscle, and bone marrow [4]. For example, stem cells implanted in an
injured rat spinal cord have survived and were able to differentiate into neurons,
astrocytes, and oligodendrocytes. Furthermore, other studies have also found that
stem cells implanted into an injured spinal cord differentiate into neurons and glial
cells [4]. The greatest challenge is providing an environment conducive to stem cell
differentiation into specific neural lineages to yield more predictable results. Although
glial progenitors have been used successfully in remyelination applications, their use as a
therapy following spinal cord injury remains to be understood [4].
Transplanted genetically modified cells, are another cell-based therapy that pose
advantages as a means to deliver a continual supply of active growth factors for nerve
regeneration such as neurotrophins. If gene expression in modified cells can be turned on
and off, it is possible that expression of nerve growth factors could be directed in a
complex manner conducive to nerve regeneration. For example, genetically modified
fibroblasts have been a highly studied model for the delivery of neurotrophins. In many
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studies, fibroblasts have been engineered to produce NGF, BDNF, NT-3, CNTF, GDNF,
and bFGF [4]. Implants of transfected fibroblasts have provided information regarding
the application of active neurotrophins locally to the nerve injury site. More advanced
studies have included a molecular "on switch" to control the genetically modified
expression of NGF in fibroblasts. Despite the advancements in cell-based therapies for
tissue engineering applications, future studies are vital in making them more applicable to
nerve repair and spinal cord injury.

CHAPTER 3
MATERIAL AND EXPERIMENTAL METHODS

This project was conducted to investigate the axon outgrowth behavior of fetal rat dorsal
root ganglia (DRG) on 2D and 3D environments composed of type I collagen from either
rat tail tendon or bovine tendon. During this study, a detailed extraction protocol was
established for the extraction of type I collagen from rat tail tendon. The validity of this
extraction protocol was analyzed through cell culture studies and protein assay
techniques that will be discussed in further detail in this chapter. Furthermore, it is
desirable to determine if type I collagen can be wet-spun into multi-filament fibers tailormade as a guiding platform for growing DRG axons cultured in vitro. The results of DRG
explant behavior on the collagen substrates will be used to determine suitable structural
material components for a nerve guide conduit as a treatment methodology for SCI.

3.1 Collagen Extraction Process
The protocol for type I collagen extraction from rat tail tendon was compiled from a
series of previous extraction techniques. The rat tail tendons were obtained from
euthanized female rats at the Rutgers-Newark Animal Facility. The tendon from severed
rat tails were utilized for the extraction of type I collagen. The age of the rats used for
this extraction process varied from 4-6 months.
The rat tails obtained from 10 female rats were stored on ice for 10-15 minutes
during transport to the NJIT CHEN facility for further processing. They were thoroughly
rinsed and scrubbed in antiseptic soap/water and 80% alcohol for sterilization purposes.
Then, the rat tails were rinsed in sterile distilled reverse osmosis water. Once the
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cleaning process was complete, the tails were stored on filter paper in Petri dishes and
frozen for 24 hours. On the following day, the tails were once again sterilized in an 80%
alcohol immersion for 15 minutes and then air-dried for 5 minutes.

Figure 3.1 Rat tail dissection

Approximately 1-1.5 cm of the tail was picked up from the small end with a
hemostat. The outer skin and hair dander was scrapped away using a scalpel 1-2 mm
distal to the point from where the hemostat is applied. Then, bone-cutting forceps were
used to fracture the vertebrate from the tip by rocking back and forth against the hemostat
positioned on the proximal end of the tail. The cracked vertebrate fragments were slowly
pulled away to separate from the rest of the tail. The attached tendons were also pulled
out along with the detached vertebrate fragments and allowed to hang freely. The free
hanging tendons were cut with scissors and placed in a pre-weighed dish of 50 ml sterile
distilled water. Then, the hemostat was repositioned 1.5 cm toward the larger end of the
tail and the procedure was repeated until all tendons were extracted from the entire length
of the tail. Once all tendons were collected into the pre-weighed dish of water, the
tendons combined with the pre-weighed 50 ml water was weighed and then subtracted
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from the mass of the water to obtain the total mass of tendons. The tendons were
extracted by immersing into 0.1% acetic acid sterile aqueous solution at (150 mL/1 g
tendon) for 5-7 days at 4 ° C with daily agitation (magnetic stir bar) for proper mixing to
ensure efficient collagen extraction from tendons.
The mixture was decanted by slowly pouring the liquid phase into 50 mL
polycarbonate centrifuge tubes without taking up the tendons and bulk matter. The raw
collagen mixture was centrifuged at 3500 RPM for 30 minutes, keeping the supernatant
(collagen), while the rest was discarded. The supernatant collagen solution was recentrifuged at 2500 RPM for 10-15 minutes, and then the supernatant phase was collected
once again while the solid pellet at the bottom was discarded.
The extracted collagen solution was transferred to dialysis tubing bags (MWCO
12,000-14,000) with lengths of 8-9 inches. The collagen extract solution was then
dialyzed overnight at 4 ° C in pre-made dialysis buffer (Na2HPO4
2
, NaH PO4 , pH 7.4). The
resulting semi-solid gel collagen extract was transferred from dialysis tubing into 50 ml
centrifuge tubes and spun at 3500 RPM for 30 min. The supernatant was discarded while
retaining the collagen pellet for further processing. The tubes containing collagen were
filled with 10-15 ml of 70% ethanol and spun at 1500 RPM for 10-15 min. The ethanol
supernatant was decanted to obtain a sterile collagen semi-solid pellet at the bottom of the
tube. The collagen semi-solid pellet can be stored up to several months at 4 ° C or
indefinitely by freezing at -70 ° C.
The collagen end product following extraction and purification is a semi-solid gel
containing excess moisture within the gel network. A dry weight form of the collagen
end product is more desirable for preparing collagen dispersions with known
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concentration by dry mass. Lyophilization, which is a freeze-drying technique, was used
to obtain dry weight collagen from the semi-solid pellet form. The collagen semi-solid
pellets were placed in an oven chamber under vacuum and dried by a high heat cycle
including a freezing phase at -20 ° C. Rat tail collagen in lyophilized form exhibited a
white porous sheet-like appearance. The dry weight lyophilized rat tail collagen was then
dissolved in 0.02M acetic acid to obtain the desired collagen concentration (BD
Biosciences, Product Sheet). In this study, dry weight lyophilized rat tail collagen was
measured accordingly and dissolved in 0.02M acetic acid to yield a collagen
concentration approximately 4.0 mg/ml.

3.2 Collagen Hydrogel Preparation
The neurite outgrowth response of fetal rat dorsal root ganglia (DRGs) in 3D hydrogel
substrates in relation to varying rat tail collagen compositions was investigated. The 3D
hydrogel was studied with particular interest since it closely mimics the natural 3D tissue
architecture of neural tissue. The presence of type I collagen in nerve tissue make 3D
collagen hydrogels a desirable component for nerve guide conduits.
The physiological environment significantly influences the physical properties of
collagen. Collagen exists as a semi-solid gel at physiological pH and temperature (7.4
and 3 7 ° C), respectively. Therefore, these known properties of collagen can be used to
create hydrogels in vitro. The stability of a hydrogel is dependent on maintaining both
physiological pH and temperature. A series of pH buffers such as 10X MEM (Sigma
MO275), HEPES, sodium bicarbonate (NaHCO 3) are required to sustain the physiological
pH of 7.4 in a collagen hydrogel.
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The preparation of a collagen 3D hydrogel involves mixing 10X MEM, HEPES,
NaHCO3 , cell culture reverse osmosis water, 1.0M NaOH, and extracted rat tail collagen
stock solution (-4.0 mg/ml). A stock solution of 10X MEM buffer solution was first
prepared by adding HEPES and NaHCO 3 to 10X MEM using the following formulation:
Desired volume of 10X MEM + 59.58 g/L HEPES +22.0 g/L NaHCO 3
For 100 ml stock solution of 10X MEM: 5.98 g HEPES, 2.20 g NaHCO 3
In this case, 100 ml of 10X MEM was measured and added to a cold centrifuge tube
followed by the addition of HEPES and NaHCO 3 .
The 10X MEM stock solution, cell culture reverse osmosis water, 1.0M NaOH,
and extracted rat tail collagen solution (-4.0 mg/ml) was mixed while working quickly on
ice to prevent sudden gelling of collagen. For 3D cell culturing of DRGs, 3.2, 2.0, 0.8,
and 0.6 mg/ml collagen gel concentrations were prepared. For 1 ml of gel, the
ingredients mentioned above were mixed on ice at specific measured volumes based on
desired collagen concentration (Table 3.1). For making collagen gel volumes other than
1 ml, the formulations were multiplied by the same factor to yield the desired overall
volume of gel.

Table 3.1 Type I Collagen Hydrogel Formulations (total volume: 1 ml)
3.2 mg/ml

2.0 mg/ml

0.8 mg/ml

0.6 mg/ml

10X MEM

100 μl

100 μl

100 μl

100 μl

Cell culture RO H20

88 μl

392 μl

697 μl

749 μl

1.0M NaOH

22 μl

20 μl

3 μl

1 μl

-4 mg/ml RT Collagen

800 μ1

500 μl

200 μl

150 μl

Collagen Hydrogels
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3.3 Dorsal Root Ganglia Isolation

Tissue isolation of dorsal root ganglia (DRG) was performed at the Rutgers-Newark
University Animal Facility. This protocol required the use of pregnant female rats
ranging in 3-5 months of age. The pregnant female rat at E15 (day 15 following mating)
was exposed with 100% CO2 for 2-5 minutes (until rat ceases breathing for 30 seconds).
If day 1 is considered the day after mating instead of day 0, then an E16 pregnant rat
would also be acceptable. Furthermore, rat pups from an E 16 pregnant rat have more
firm spinal cords enabling an optimal yield of DRGs compared to premature or late stage
rat pups.
The rat was placed on its back and the abdomen was sterilized with 70% ethanol.
An incision was made from the tail to the thorax using scissors and forceps. In order to
ensure death again, a thoractomy was performed by puncturing the diaphragm with
scissors. A clean set of scissors and forceps were then used
to perform a C-section by
2
dissecting out the uterus and placing in a sterile 100 mm dish. The embryos were
removed from the uterus while working under the dissection hood. The embryos were
placed in Lebovitz L-15 or other non-CO sensitive balanced medium.
Once the placenta membrane lining was removed from the embryos, the heads were
cut off the embryos between the skull and the first vertebra. Micro-scissors or a micro
knife was used to cut on the caudal side of the pronounced bump on the back of the head
located under the ear and under the snout. The purpose of this step was to ensure that
some of the brain stem is left over to handle for pulling out the cord. The anterior portion
of the abdomen and limbs were then removed with the embryo on its side using the micro
knife. The embryo was placed on its back, and the remaining viscera were removed with
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fine forceps (Dumont #5) until there is a clear view of the vertebral column. A set of fine
forceps (Dumont #5) was used to pinch through the vertebral column beginning at the
rostal end. The brainstem and ménages were grasped with a #4-45 forceps and pulled
straight up. Once taken out, the brainstem and ménages were placed in a 60mm dish with
L-15 balanced medium. A fresh pair of Dumont #5 biologine-tip forceps was used to
pluck off the DRGs from the isolated spinal cords. The DRGs were then placed in a 1.5
mL centrifuge tube with L-15 medium to be prepared for cell plating.

3.4 Cell Culturing of Dorsal Root Ganglia on 2D Collagen Substrates
The neurite outgrowth potential of fetal DRG explants on 2D plates coated with extracted
type I rat tail collagen and type I bovine tendon collagen was analyzed in this study. A
set of 35 mm Petri dishes was coated with 10 μg/m1 of poly-L-lysine (PLL) as a base
substrate for adhesion of DRG explants onto plastic dishes. Aliquots containing 1 ml of
pre-made 1 mg/ml PLL were used to prepare a PLL concentration of 10 µg/ml.
Therefore, 10 µg/ml PLL was made by adding 25 ml of sterile distilled water to 250 pi of
PLL. The dishes were allowed to sit for a minimum of 1 hr to ensure PLL adsorbs onto
the bottom surface of the plastic. Once a thin layer of PLL had adsorbed onto the
surface, the PLL solution was removed, and the dishes were allowed to air-dry for 1 hr
inside the tissue culture hood. Then, the dishes were rinsed three times (3x) with sterile
cell culture water. The dishes were once again air-dried in the hood for a minimum of 1
hr prior to collagen coating. Once dried, a set of dishes can be prepared in advance and
stored at 4 ° C for up to two weeks. An ammonium hydroxide (NH4OH) chamber was
constructed using a 100x10 mm dish with the lid taped to a filter paper soaked in 1 mL
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NH4OH. Then, approximately 25-50 μL of extracted type I collagen from rat tail and
bovine were applied and spread onto the surface of previously coated PLL dishes. The
ammonium hydroxide vapors induced gelling of the collagen layer within 2-3 minutes.
DRG explants were plated as 4 explants evenly spaced in the middle of the dish as 5µL
droplets. The DRGs were given 2 hours for adhesion onto the dishes. Once time was
given for adhesion, approximately 2 ml of neuralbasal growth media was added. The
neuralbasal growth media was made prior to DRG isolation by mixing 98 ml of
Neuralbasal medium with B-27 and 0.4-0.5 mM L-Glutamine, 1 ml of 1% FBS heat
inactivated, 1 ml of 20% Glucose Sigma (25g in 100 ml water), and 1 μg of 10 ng/ml
NGF (Gibco 13290-010) to make an approximately 100 ml stock solution of DRG
neuralbasal growth media. The media in the dishes were changed every 2 days and the
images were taken at day 1, 5, and 9 for axonal growth studies on the 2D substrates. The
samples were viewed using a Nikon inverting microscope equipped with phase-contrast
optics, fluorescent illumination, selective filters, and a digital image capture system. The
images were later imported into Image J software program for performing neurite
outgrowth measurements on each of the 2D substrates at day 1, 5, and 9. For each DRG
isolation experiment, a set of 3 dishes (n = 3) was prepared for each collagen source: rat
tail (extracted), bovine tendon (extracted), and commercial (BD Biosciences). The
analysis of neurite outgrowth on 2D substrates was performed twice (n = 6) for each
group of collagen substrates. DRGs were visualized using the Vybrant CFDA SE Cell
Tracer Kit (Molecular Probes, Invitrogen).
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3.5 Cell Culturing of Dorsal Root Ganglia on 3D Collagen Hydrogels
Dorsal root ganglia (DRG) neurite outgrowth in a hydrogel is a desirable approach since
neural tissue is naturally grown in a 3D in vivo environment. Fetal DRG explants were
plated within 3D type I collagen hydrogels of varying collagen concentrations (0.6, 0.8,
2.0, and 3.2 mg/mL) to study their neurite outgrowth. In a 24-well plate, a DRG explant
was plated such that it is sandwiched between two collagen hydrogel layers. A DRG
explant was plated on the bottom gel layer as a 10 ill drop and allowed 2 hours for
adhesion to the surface. Then, the top gel layer was applied to embed the DRG explant
within the two layers. The bottom layer was approximately 300 μm while the second top
layer was roughly 100-150

μ,111 thick.

Once the top gel layer had solidified, approximately

2 ml of neuralbasal growth media, which was prepared with NGF and mitotic inhibitors
as mentioned earlier, were added to the surface of the gel. In this case, minimizing the
thickness of the overall hydrogel was important to enable diffusion of nutrients down to
the DRG explants embedded within the gel.
The media in the wells were changed every 2 days and the images were taken at
day 1, 5, and 9 for axonal growth studies within the 3D hydrogels. The samples were
viewed using a Nikon inverting microscope equipped with phase-contrast optics,
fluorescent illumination, selective filters, and a digital image capture system. The images
were then imported into Image J software program for performing neurite outgrowth
measurements on each of the 3D hydrogels at day 1, 5, and 9. A DRG isolation was
often followed by a set of experiments consisting of two 24-well plates with two rows of
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(n = 12) wells for each collagen gel concentration. This set of experiments was repeated
twice for extracted rat tail type I collagen. The analysis of neurite outgrowth on 3D
hydrogels was performed in triplicate (n = 9) for each collagen gel concentration.

3.6 Total Protein Assay for Type I Collagen Quantification
The validity of the type I collagen extraction process was assessed by quantifying protein
concentration. There are several approaches to determine protein concentration including
total protein assay. In this study, bicinchoninic acid (BCA) protein assay was the method
of choice for assessing type I collagen concentration. The BCA protein assay (Pierce
Biotechnology) is a colorimetric detection and quantification of total protein based on a
bicinchoninic acid, which is a detergent-compatible compound often used as a
fluorescence probe for colorimetric detection. This method consists of a well-known
reaction mechanism involving the reduction of Cu 2+ to Cu1+ by protein in alkaline
medium with the highly sensitive and selective colorimetric detection of Cu t ' using a
unique reagent containing bichinchonic acid. The chelation of two molecules of BCA
with a Cut ' ion yields a purple-colored reaction product in this assay. The water-soluble
complex formed from this reaction exhibits a strong absorbance at approximately 570 nm
with a nearly linear behavior for increasing protein concentrations over a broad working
range (0.02 — 2.00 mg/ml).
The colorimetric detection of protein is based on the macromolecular structure of
protein such as the number of peptide bonds and the presence of particular amino acids
(cysteine, tryptophan, and tyrosine). The presence of these amino acid residues in protein
is often attributed to color formation with BCA. In this assay, protein concentrations
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were determined and reported with reference to standards of common proteins such as
bovine serum albumin (BSA). A series of dilutions of known concentration were
prepared from BSA and assayed together with the protein unknowns before the
concentration of each unknown is determined by extrapolation based on the standard
curve.
A set of diluted bovine serum albumin (BSA) standards was prepared in several
clean vials or micropipette tubes using the same diluents. A 1 ml ampule of 2.0 mg/ml
albumin standard was adequate to prepare a set of diluted standards for the microplate
procedure (Table 3.2).

Table 3.2: Dilution Scheme for BSA Standards Preparation (Microplate Set-up)
Vial

Volume of Diluent

Volume and Source of BSA

Final BSA
Concentration

A

0

300 μl

2.0 mg/ml

B

125 μl

375 ml

1.5 mg/ml

C

325 μl

325 ml

1.0 mg/ml

D

175 μl

175 ml

0.750 mg/ml

E

325 μ1

325 ml

0.500 mg/ml

F

325 ml

325 ml

0.250 mg/ml

G

325 ml

325 ml

0.125 mg/ml

H

400 ml

100 ml

0.025 mg/ml

I

400 ml

0

0 mg/ml = Blank
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The BSA standards were made by adding phosphate buffer saline (PBS) to 2.0 mg/ml
albumin standard and thoroughly mixing in the micropipette tubes using a vortex
machine and microcentrifuge. Once prepared, the BSA standards can be stored at -20 ° C.
The extracted rat tail type I collagen and commercial rat tail type I collagen (BD
Biosciences) were diluted 10X and 20X in 0.02M acetic acid or PBS for total protein
assay. The diluents 0.02M acetic acid and PBS were selected to investigate if
colorimetric reaction of type I collagen was affected by using different diluents. In this
protein assay, the working reagent (WR) consisting of BCA was prepared by mixing 50
parts of reagent A with 1 part of reagent B (50:1, reagent A:B).
A 96-well microplate was used to load the BSA standards and unknowns (Table
3.3). The unknowns in this protein assay were the following: extracted rat tail type I
collagen, commercial rat tail type I collagen (BD Biosciences), 0.02M acetic acid (AA),
and PBS at 10X and 20X dilutions. A 10X dilution of collagen was prepared by adding
135 ml of AA or PBS to 15 ml of extracted rat tail collagen or commercial rat tail
collagen (BD Biosciences). The 20X dilution of collagen was made by adding 142.5 ml
of AA or PBS to 7.5 ml of extracted rat tail type I collagen or commercial rat tail type I
collagen (BD Biosciences). For the microplate procedure, only 200 ml of WR reagent
was required for each sample. When reagent B was first added to reagent A, turbidity
was quickly observed but later disappeared upon mixing to yield a clear, green WR. In
this experimental set-up, 0.5 ml of reagent B was added to 25 ml of reagent A to make
the WR. Once all the samples were prepared and loaded into the 96-well microplate, a
microplate reader programmed with Soft Max Pro Software was used to measure
absorbance values of the samples at 570 nm.
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Table 3.3: BCA Protein Assay Experimental Set-up (96-well Microplate)
A

Std01

Std02

Std03

Std04

Std05

Std06

Std07

Std08

Std09

mg/ml 2.0

1.5

1.0

0.75

0.5

0.25

0.125

0.025

0

B

Std02

Std03

Std04

Std05

Std06

Std07

Std08

Std09

mg/ml 2.0

1.5

1.0

0.75

0.5

0.25

0.125

0.025

0

C

Std02

Std03

Std04

Std05

Std06

Std07

Std08

Std09

mg/ml 2.0

1.5

1.0

0.75

0.5

0.25

0.125

0.025

0

D

RT

RT

RT

RT

BL

RT

RT

RT

RT

(AA)

(AA)

(AA)

(AA)

(PBS)

(PBS)

(PBS)

(PBS)

10x

10x

10x

10x

10x

10x

10x

10x

RT

RT

RT

RT

RT

RT

RT

RT

(AA)

(AA)

(AA)

(AA)

(PBS)

(PBS)

(PBS)

(PBS)

20x

20x

20x

20x

20x

20x

20x

20x

F

AA

AA

AA

AA

BL

PBS

PBS

PBS

PBS

G

BD

BD

BD

BD

BL

BD

BD

BD

BD

(AA)

(AA)

(AA)

(AA)

(PBS)

(PBS)

(PBS)

(PBS)

10x

10x

10x

10x

10x

10x

10x

10x

BD

BD

BD

BD

BD

BD

BD

BD

(AA)

(AA)

(AA)

(AA)

(PBS)

(PBS)

(PBS)

(PBS)

20x

20x

20x

20x

20x

20x

20x

20x

E

H

Std01

Std01

BL

BL

*Std: BSA standards, RT: extracted rat tail type I collagen, BD: extracted bovine tendon
type I collagen, AA: 0.02M acetic acid, PBS: Phosphate Buffer Saline
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3.7 SDS-Polyacrylamide Gel Electrophoresis (PAGE)
Electrophoresis is a process in which charged molecules are transported through a solvent
by an electrical field. This technique is a very simple, rapid, and sensitive analytical tool
for separating proteins and nucleic acids. Any ion or molecule that carries a charge will
migrate when placed in an electric field. Most biological molecules carry a net charge at
any pH besides their isoelectric point and tend to migrate in relation to their charge
density. When exposed to an electric field, the mobility of a biological molecule such as
a protein is dependent on many factors including field strength, net charge on the
molecule, size and shape of the molecule, and ionic strength and properties of the
medium through which the molecules migrate.
Agarose and polyacrylamide gels are two types of support matrices used in
electrophoresis. A support matrix serves as a porous media and behaves like a molecular
sieve for migrating ions and molecules. The molecular sieving function of the matrix
depends on the gel pore size of the matrix. Agarose, which has a large pore size, is ideal
for separating macromolecules such as nucleic acids and protein complexes.
Polyacrylamide has a smaller pore size and is more suitable for separating most proteins
and smaller nucleic acids. In this study, polyacrylamide gels were used to run
electrophoresis in order to investigate the purity of extracted rat tail type I collagen in
comparison to the control commercial rat tail type I collagen (BD Biosciences).
Polyacrylamide gels are generated by the polymerization of acrylamide
monomers into long chains and the cross-linking of these long chains by bifunctional
compounds such as N,N-methylene-bisacrylamide at certain concentration of total
monomer (%T) and proportion of cross linker (%C). If the acrylamide monomer
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concentration (%T) is high, the overall pore size of the gel is quite small. A gel with a
smaller pore size results in better resolution of low molecular weight molecules.
Therefore, large molecules resolve well on low percentage gels while small molecules are
best resolved on high percentage gels. The percentage gel is usually selected based on
the size of the molecule being investigated.
Electrophoresis can be performed under denaturing conditions by using an anionic
detergent such as sodium dodecylsulfate (SDS), which denatures and unfolds the proteins
by wrapping around the hydrophobic portions of the protein. The resulting SDS-protein
complexes are highly negatively charged and migrate through the gel based on their size
rather than charge. Buffer systems are another essential component of electrophoresis
and can be either continuous or discontinuous. A continuous buffer system uses only one
buffer in the gel and the running buffer. In contrast, a discontinuous buffer system
involves a different gel buffer and running buffer. Furthermore, a discontinuous buffer
system consists of using at least two gel layers of different pore sizes, the stacking and
resolving gel. The benefits to using a discontinuous buffer system are the concentration
of the sample and higher resolution. In this study, SDS-PAGE was performed using a
discontinuous buffer system using a running buffer different from the two gel buffers
used to make the stacking and resolving gels.
The implementation of SDS-PAGE involved the preparation of several stock
solutions and buffers prior to running an experiment. Acrylamide/Bis (30% T, 2.67% C)
was either used pre-made or prepared by dissolving 87.6 g of acrylamide and 2.4 g of
N,N-bis-methylene-acrylamide in 300 ml of nanopure water. Once prepared, the
acrylamide/bis solution was stored at 4 ° C in the dark for up to 30 days. Then, 10% (w/v)
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SDS was either used pre-made or prepared by dissolving 10 g of SDS in 90 ml of
nanopure water while gently stirring and bringing the total volume up to 100 ml with
water. Buffers for the resolving gel and stacking gel were prepared in stock by making
1.5M Tris-HCl, pH 8.8 (resolving gel) and 0.5M Tris-HCl, pH 6.8 (stacking gel). The
1.5M Tris-HCl buffer was prepared by adding 27.23 g of Tris base to 80 ml of nanopure
water while adjusting to pH 8.8 by adding 6N HCl. The total volume was then brought
up to 150 ml with nanopure water, and the solution was then stored at 4 ° C. The 0.5M
Tris-HCl buffer was prepared by adding 6.0 g of Tris base to 60 ml of nanopure water
while adjusting to pH 6.8 by adding 6N HCl. The total volume was then brought up to
100 ml with nanopure water, and the solution was then stored at 4 ° C. The sample buffer
(SDS reducing buffer) was used pre-made or prepared by mixing 3.55 ml of nanopure
water, 1.25 ml of 0.5M Tris-HCl, 2.5 ml of glycerol, 2.0 ml of 10% (w/v) SDS, and 0.2
ml of 0.5% (w/v) bromophenol blue to yield a total volume of 9.5 ml. The sample buffer
was then stored at room temperature until needed. The 10X electrode (Running) buffer,
pH 8.3 was also used pre-made or prepared by dissolving 30.3 g of Tris base, 144.0 g of
Glycine, and 10.0 g of SDS in nanopure water. The total volume was brought up to 1 L
with nanopure water. The 10X running buffer was then stored at 4 ° C until further needed
for the experiment. The polymerizing agent ammonium persulfate (APS) was prepared
fresh on the day of the experiment. The 10% APS was made by dissolving 100 mg of
APS in 1 ml of nanopure water.
A 7% polyacrylamide gel was prepared by making the monomer solution by
adding the following ingredients: 5.1 ml of nanopure water, 2.3 ml of 30% degassed
acrylamide/bis, 2.5 ml of gel buffer (resolving gel buffer or stacking gel buffer), and 0.1
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ml of 10% (w/v) SDS. For preparing the resolving gel, 50μl of 10% APS and 5 μl of
TEMED were added to the monomer solution and polymerization was initiated by gently
swirling the solution. The stacking gel was made by adding 50 μl of 10% APS and 10 μl
of TEMED to the monomer solution while initiating polymerization by gently swirling
the solution.
The samples analyzed in SDS-PAGE were the extracted rat tail type I collagen
and the commercial rat tail type I collagen (BD Biosciences). The maximum volume
allowed for a 10 well comb of 1.0 mm thickness is 25 μl . Therefore, approximately 25 μl
of each of the collagen samples were prepared by adding calculated volumes of sample
buffer and 10X running buffer to each of the samples. Approximately 50 μl of BMercaptoethanol was added to 950 μl of pre-made sample buffer prior to adding to the
samples. The samples were then heated in a water bath at 95oC for 4 min to initiate
denaturation of collagen samples.
While the samples were in the water bath, the gels were casted by slowly pouring
the resolving gel solution into the gel cassette. Once the resolving gel had solidified, the
stacking gel solution was poured on top and allowed to solidify. A few drops of
methanol were added to the very top of the casting gel to ensure a smooth surface on top
of the gel during solidification. The 10-well comb was carefully inserted into the top of
the gel to form the imprint wells for sample loading.
The gel solidified after 10 min and the 10-well comb was slowly taken out. Once
the gel was placed into the XCell SureLock MiniCell electrophoresis chamber
(Invitrogen Life Technologies), approximately 600 ml of 10X running buffer was poured
into the upper chamber. While the gel was in the running buffer, the samples were then
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loaded into the wells. A protein standard ladder was loaded into the first well and
extracted rat tail and commercial rat tail collagen was loaded into the next two adjacent
wells. The top of electrophoresis chamber was then connected to the anode and cathode
ends of the core chamber. The ends of the electrode wires were connected to the positive
and negative terminals of the Thermo EC Series 90 Power Supply (Thermo EC, Inc.) The
power supply was programmed to a constant voltage of 125 V and a current range of 3040 mA. Electrophoresis proceeded for approximately 90 min or until the bands run to the
end of the gel. Once electrophoresis was completed, the power supple was turned off,
electrodes disconnected, and the gel removed from the XCell SureLock MiniCell
chamber. The gel then went through a series of staining in coomassie blue followed by
several de-staining steps in order to visibly see the bands of the protein samples.
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3.8 Wet Spinning of Type I Collagen
The 3D collagen hydrogel appears to be an essential supporting matrix for sustaining
regenerating axons. However, additional components for facilitating guided axonal
growth are most desirable for creating a nerve guide conduit. In this study, the aim was
to fabricate sub-micron (2-10 μm) collagen fibers for use as a guiding component for
DRG axonal outgrowth. The wet spinning technique was used to create collagen fibers
from collagen dispersions of bovine type I collagen in 0.012N HCl. Collagen
microfilament fibers were synthesized from 2% and 5% wt bovine collagen/0.012N HCl
dispersions in ethanol. The protocol for making collagen monofilaments through the wet
spinning process involves the following materials: collagen dispersions, acetone,
ammonium hydroxide, and a pH meter.
An essential component of the wet spinning technique is the coagulation solution,
which facilitates gelling of collagen dispersions. The coagulation solution was prepared
by filling a container (glass or metal) with acetone. Ammonium hydroxide (NH4OH) was
added drop at a time into the acetone bath while the pH was monitored upon mixing the
coagulation solution. The addition of ammonium hydroxide continued until the pH
reached 9. The bovine collagen dispersions had a pH of approximately 4.5.
A syringe was filled with 5-10 ml of bovine collagen solution to be wet spun and
the 17-gauge needle was secured to the syringe. The tip of the needle was slightly dipped
into or just above the coagulation bath in order to extrude the collagen solution into the
bath. The container used in this experimental set-up had a long and flat bottom. The tip
of the syringe needle was moved from one end of the container to the other end as evenly
as possible. This set-up seemed more desirable since a deep and narrow container would
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only result in fibers that tend to tangle upon taking them out of the bath. The syringe was
placed in a syringe pump and set to a flow rate of 10 ml/min. The extruded collagen
dispersions coagulated into fibers within 5-10 min in the coagulation bath. The fibers
were drawn out of the bath using a glass rod. The formed fibers were then hung on a
"clothes line" to air dry to ensure efficient evaporation of solvent. During this initial
stage of fiber development, the fibers were handled with delicate care since the fibers
tend to break easily. Collagen dispersions from rat tail collagen yielded fibers that were
too compliant. When wet-spun fibers from rat tail collagen were taken out of the bath to
dry, they tended to break apart very easily. Therefore, collagen dispersions from bovine
tendon were more favored for wet spinning collagen micro-fibers in this study. The
fibers were allowed to air dry for 24 hr and then viewed at 4X magnification using a
Nikon inverting microscope equipped with phase-contrast optics, fluorescent
illumination, selective filters, and a digital image capture system. The images were later
imported into Image J software program for characterizing fiber diameter of the wet spun
collagen fibers. The protocol for wet spinning was repeated with an 18-gauge syringe
needle to produce smaller collagen fibers at the same flow rate.

CHAPTER 4
RESULTS AND DISCUSSION

Fetal dorsal root ganglia (DRGs) were successfully cultured on both 2D collagen
substrates and 3D collagen hydrogels. There was no inhibition of neurite growth during
the 1, 5, and 9 day periods in duplicate studies for both 2D and 3D collagen substrates. A
significant finding in this study showed that the DRGs grew just as well on extracted rat
tail collagen as the commercial rat tail collagen from BD biosciences. Therefore,
extracted rat tail collagen was conducive to DRG axon outgrowth. A comparison of
neurite growth on 2D extracted rat tail and bovine tendon type I collagen surfaces
revealed that bovine tendon collagen restricts DRG neurite extension. The axonal
outgrowth response of DRGs in extracted 3D rat tail collagen hydrogels with varying
collagen concentrations was expected. Collagen microfilaments were successfully wet
spun from 2.0% and 5.0% wt extracted type I bovine tendon collagen dispersions in
ethanol.

4.1 DRG Neurite Outgrowth on 2D Collagen Plates
The neurite outgrowth of dorsal root ganglia (DRGs) on 2D collagen dishes was imaged
at 4X magnification using a Nikon inverting microscope equipped with phase-contrast
optics, fluorescent illumination, selective filters, and a digital image capture system. The
images were then imported into Image J software program for performing neurite
outgrowth measurements. DRG neurite measurements were determined by dividing the
DRG into top, bottom, left, and right quadrants. Five radial measurements were taken
from each quadrant of the DRG neurites starting from the edge of the cell body to the tip
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of the neurite. An average was taken of the five measurements from each quadrant and
then a total average was further calculated from the four quadrants to determine the
overall DRG neurite outgrowth.

Some plates were stained with Vybrant to aid in

imaging and measurement of DRG neurites at discrete time points. DRGs plated on 2D
type I collagen dishes exhibited a gradual increase in neurite growth when monitored at
days I, 5, and 9 (Figure 4.1 a-c). DRG neurites on 2D extracted rat tail collagen
appeared more dense compared to neurites on 20 extracted bovine tendon collagen.

a)

b)

c)

d)

Figure 4.1 a) Extracted Type I Rat Tail Collagen Day I Vybrant stain, b) Extracted Type
I Bovine Collagen Day 1 Vybrant Stain, c) Extracted Type I Rat Tail Collagen Day 5, d)
Extracted Type I Bovine Collagen Day 5, 4X Magnification

DRG neurite outgrowth on 2D collagen substrates was studied in two separate
experiments under the same conditions. DRGs exhibited a linear relationship in axonal
outgrowth on 2D extracted rat tail collagen over the three discrete time points for both
experiments. The second experiment revealed similar neurite outgrowth behavior over
days I, 5, and 9 and confirmed DRG neurite growth response on 2D extracted rat tail type
I collagen coatings. An average of DRG neurite outgrowth measurements (n=6) for each
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day was calculated using both experiments. Standard deviation of neurite outgrowth
measurements was determined for each day. The highest deviation was seen in DRG
neurite outgrowth at day 9 (Figure 4.2).

Figure 4.2 Plot of Mean DRG Axonal Growth at Days 1, 5, and 9 on 2D Extracted Rat
Tail Type I Collagen Plates

The standard deviation for days 1, 5, and 9 was 8.89, 23.24, and 51.37,
respectively. The neurite outgrowth on 2D extracted rat tail collagen increased from 32.4
pm up to an average of 272.6 pm by 9 days. The neurites appeared to be numerous and
extended with ease on 2D extracted rat tail collagen.
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The growth response of DRG neurites on extracted type I bovine tendon collagen
was a linear relationship, but neurite extension appeared more limited over 9 days. In the
first experiment, DRG neurites were limited to approximately 13 pm after day 1. The
number of the neurites seemed less dense on bovine collagen compared to rat tail
collagen. This observation may be due to the higher mechanical properties of bovine
collagen, leading to a slight impedance of neurite outgrowth. The DRGs still appeared
viable as their neurites continued extending over 9 days despite the mechanical
constriction of bovine collagen. A second study of DRG neurite growth response on 2D
bovine collagen surfaces conducted under the same conditions revealed similar neurite
outgrowth behavior over days 1, 5, and 9 and confirmed DRG neurite growth response on
2D extracted bovine tendon type I collagen coatings. An average of DRG neurite
outgrowth measurements (n=6) on 2D bovine tendon collagen dishes for each day was
calculated using both experiments (Figure 4.3). Standard deviation of neurite outgrowth
measurements on 2D bovine collagen surfaces was determined for each day. The highest
deviation in DRG axonal growth on 2D bovine collagen was observed at day 9. The
standard deviation for days 1, 5, and 9 was 9.31, 18.76, and 21.67, respectively. The
neurite outgrowth on 2D extracted bovine tendon collagen increased from 14.8 μm up to
an average of 156.8 pm by 9 days. The morphology and number of neurites on 2D
bovine collagen had notable differences compared to rat tail collagen. The neurites
seemed more sparse and restricted in extension on bovine collagen coated dishes.
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Figure 4.3 Plot of Mean DRG Axonal Growth at Days 1, 5, and 9 on 2D Bovine Tendon
Type I Collagen Plates

A study of DRG neurite outgrowth was also conducted using commercial rat tail
type I collagen (BD Biosciences). Axonal growth was investigated on commercial rat tail
type I collagen at two separate experiments under the same conditions. Commercial rat
tail type I collagen served as a comparison study with the extracted rat tail type I
collagen. DRGs also exhibited a linear relationship in axonal outgrowth on 2D
commercial rat tail collagen over the three discrete time points for both experiments. In
the first experiment, DRGs grown on commercial rat tail type I collagen showed neurite
growth up to approximately 298 μm after 9 days. The second study revealed a similar
DRG neurite growth response on the 2D commercial rat tail type I collagen coatings.
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The average of axonal growth measurements (n=6) from the two experiments
were calculated and plotted along with standard deviations for each day (Figure 4.4).

Figure 4.4 Plot of Mean DRG Axonal Growth at Days 1, 5, and 9 on 2D Commercial Rat
Tail Type I Collagen Plates

Standard deviation of neurite outgrowth measurements on 2D commercial rat tail
collagen surfaces for each day appeared similar to outgrowth studies on 2D extracted rat
tail collagen. The highest deviation in DRG axonal growth on 2D commercial rat tail
collagen was once again observed at day 9. The standard deviation for days 1, 5, and 9
was 9.66, 23.85, and 45.63, respectively. The neurite outgrowth on 2D commercial rat
tail collagen increased from 30 pm up to an average of 299.6 μm by 9 days. The
morphology and number of neurites on 2D commercial rat tail collagen revealed many
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similarities to extracted rat tail collagen. The neurites were quite dense on the
commercial rat tail collagen and exhibited optimal growth along the surface.
DRG neurite outgrowth over the three discrete time points exhibited a linear
relationship for all 2D collagen substrates (Figure 4.5). Neurite outgrowth was most
optimal after 9 days on commercial rat tail type I collagen (BD Biosciences). Extracted
rat tail collagen closely matched the growth response of commercial rat tail collagen for
days 1 and 5. Furthermore, the standard deviation of neurite outgrowth values for
extracted rat tail collagen was similar to commercial rat tail collagen over 9 days. A
comparison of 2D neurite outgrowth on all the 2D collagen substrates, once again
revealed the limited axon growth on bovine collagen. A common finding in all 2D
collagen substrates was the increase in standard deviation among the neurite outgrowth
values from day 1 to day 9.

Figure 4.5 Comparison of Mean DRG Neurite Growth on all 2D Collagen Substrates
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4.2 DRG Neurite Outgrowth on 3D Collagen Hydrogels
The neurite outgrowth of dorsal root ganglia (DRGs) on 3D collagen hydrogels was
imaged at 4X magnification using a Nikon inverting microscope equipped with phasecontrast optics, fluorescent illumination, selective filters, and a digital image capture
system. The images were then imported into Image J software program for performing
neurite outgrowth measurements. DRG neurite measurements within 3D collagen
hydrogels were taken similarly as with 2D collagen dishes by dividing the DRG into top,
bottom, left, and right quadrants. Once again, five radial measurements were taken from
each quadrant of the DRG neurites starting from the edge of the cell body to the tip of the
neurite. An average was taken of the five measurements from each quadrant and then a
total average was further calculated from the four quadrants to determine the overall
DRG neurite outgrowth. For 3D neurite studies, the DRGs were embedded and grown
inside collagen hydrogels contained within wells of a 24-well plate. Although some
wells were stained with Vybrant to aid in imaging and measurement of DRG neurites,
Vybrant staining within gels proved to be very difficult since the entire background was
also stained along with the neurites. Therefore, image analysis and neurite measurements
were performed using only phase-contrast images of the DRGs.
As expected, DRGs plated on 3D type I collagen gels also exhibited a gradual
increase in neurite growth when monitored at days 1, 5, and 9. DRG axonal growth in
3D collagen hydrogels was repeated twice under the same conditions and collagen gel
concentrations. The collagen gel concentration was directly related to the collagen gel
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stiffness. Three-dimensional DRG axonal growth was later compared to twodimensional outgrowth studies. In the first experiment, DRG neurites extended up to an
average of 338 1-1M in length over 9 days in 0.8 mg/ml collagen gels. During days 1 and
5, DRG neurite outgrowth was highest for 0.6 mg/ml gels and gradually decreased in a
nearly linear behavior with corresponding increase in collagen gel concentrations. By
day 9, DRG neurite outgrowth was optimal in 0.8 mg/ml gels. The axonal growth
response became more nonlinear over 9 days of cell culture.
The second experiment under the same conditions yielded a similar response in
DRG neurite outgrowth over time. DRG neurites extended up to an average of 361 pm in
length over 9 days in 0.8 mg/ml collagen gels. For the second experiment, DRG neurite
outgrowth was once again highest for 0.6 mg/ml gels during days 1 and 5 and gradually
decreased in a nearly linear behavior with corresponding increase in collagen gel
concentrations. By day 9, DRG neurite outgrowth was optimal in 0.8 mg/ml gels.
Neurite lengths were significantly lower for 2.0 and 3.2 mg/ml gel concentrations after
day 9 in both experiments. The DRG neurite growth measurements were averaged
between the two experiments and plotted along with standard deviation. Standard
deviation in neurite outgrowth values was very small for day 1 but was more significant
in days 5 and 9. DRG neurites grew up to an average of 349 pm by day 9 (Figure 4.5).
Collagen gel concentration of 0.8 mg/ml appeared to be the most suitable matrix material
for supporting DRG axonal growth over 9 days.
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Figure 4.6 Plot of Mean DRG Axonal Growth at Days 1, 5, and 9 in 3D Extracted Rat
Tail. Collagen Hydrogels at 0.6, 0.8, 2.0, and 3.2 mg/ml collagen concentrations

A comparison of 2D and 3D DRG axonal outgrowth revealed that DRGs slightly
favored the 3D environment over 9 days in cell culture (Figure 4.7). DRG neurite growth
at day 1 was very close for both dimensions but performed better in 3D at days 5 and 9.
The standard deviation in neurite outgrowth at day 9 in 3D was much lower than in 2D.
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Figure 4.7 Plot of Mean DRG Axonal Growth at Days 1, 5, and 9 in 2D vs. 3D Extracted
Rat Tail Collagen

4.3 Total Protein Assay for Type I Collagen Quantification
In total protein assay, extracted rat tail type I collagen and commercial rat tail type I
collagen (BD Biosciences) were both quantified by colorimetric detection using the BCA
reagent. PBS and 0.02M acetic acid were both used as diluents to determine which one
would be more suitable for collagen detection in this assay. An analysis of the optical
density values of both the extracted rat tail type I collagen and commercial rat tail type I
collagen revealed high values when acetic acid was used as the diluent for both 10X and
20X dilutions (Table 4.1). Since collagen samples in PBS did not yield strong
absorbance values, collagen unknowns in acetic acid were used to determine a rough
estimate of collagen concentration. Acetic acid appeared to be a better diluent since the
collagen was already in solution with 0.02M acetic acid for both the extracted and
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commercial rat tail type I collagen. The average optical density for the extracted rat tail
type I collagen in acetic acid was 0.18075 in 10X dilution. Furthermore, the average
optical density for commercial rat tail type I collagen in acetic acid at 10X dilution was
0.1715. The average optical density for extracted rat tail collagen and commercial rat tail
collagen in acetic acid at 20X dilution was 0.1123 and 0.0975, respectively. A best-fit
linear regression line was made by plotting the optical density values and corresponding
concentrations of the BSA standards (Figure 4.10). The equation y = 1.0449x + 0.0706
was determined from the best-fit line, where y is the optical density value and x
represents concentration. The correlation of optical density to concentration for the BSA
standards was 0.9899. The concentrations of the collagen unknowns were then calculated
using the equation. The calculated concentration of extracted rat tail type I collagen and
commercial rat tail type I collagen at 10X dilution was approximately 0.1054 and
0.09656 mg/ml, respectively. Furthermore, the concentration for extracted rat tail type I
collagen and commercial rat tail type I collagen at 20X dilution was calculated to be
approximately 0.03986 and 0.02574 mg/ml. The optical density and concentration values
for both extracted rat tail type I collagen and commercial type I collagen for both
dilutions closely matched each other indicating that the extracted rat tail type I collagen
exhibited similar chemical properties to the commercial rat tail type I collagen based on
absorbance values from the protein assay. BCA total protein assay was sufficient to
confirm that there were similar chemical properties of extracted rat tail type I collagen to
the control commercial rat tail type I collagen (BD Biosciences). However, other protein
detection techniques may be more accurate and should be considered.
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Tabte 4.1 Optical Density and Concentration Values of Collagen Unknowns in BCA
Total Protein Assay

Unknowns RT
D

.

0.1·78
0.184
0.175
0.186
0.18075

0.105416786

Unknowns BD

Samples; dilution:

G

Unknowns RT
E

0.162
0.165
. 0.1790.18
0.1715
0.096564265

0.057565317

Unknowns BD
H

0.075
0.083
0.097
0.085
0.085

0.013781223

20X

Samples; dilution:

0.118
0.11225

0.076
0.077
0.073
0.077
0.07575

0.039860274

0.004928701

0.108
0.112

,

20X

Samples; dilution:

0.093
0.099
0.095
0.103
0.0975

0.046
0.052
0.048
0.053
0.04975

0.02574409

-0.019954063

."'

Ave
Concentration
(mg/mI)

lOX

.

.

0;11.1
Ave
Concentration
(mg/mt)

0.127
0.131
0.136
0.129
0.13075

"

Ave
Concentration
(mg/mt)

Ave
Concentration
(mg/mt)

lOX

Samples; dilution:
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Concentration values of extracted rat tail collagen and commercial rat tail
collagen were mnch lower than the expected concentration (-4.0 mg/ml RT and 3.63
mg/m] BD). The concentration of the commercial rat tail collagen as highlighted by the
circle on the standard curve was approximately 0.966 mg/ml (Figure 4.8). Furthermore,
the concentration of the extracted rat tail collagen also highlighted on the graph was
approximately 1.05 mg/m!.

BCA Prote in Assay Standam Curve

y = 1.0449x + 0.0706
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Figure 4.8 BCA Total Protein Assay (Standard Curve ofBSA Standards)
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4.4 SDS-Polyacrylamide Gel Electrophoresis (PAGE)
The results ofSDS-PAGE revealed that the extracted rat tail type I collagen was
qualitatively similar to the commercial rat tail type I collagen based on the banding
patterns. Although the bands for the extracted rat tail type I collagen matched up well to
the bands for commercial rat tail collagen, only the bands for commercial rat tail collagen
were more visible. The protein standard ladder was used as a comparison to quantify the
protein bands of the sample unknowns. Doublet bands present at 235 kDa and 215 kDa
and another pair of doublets at 130 kDa and 115 kDa are characteristic of rat tail type I
collagen. These two doublet pairs were present in both commercial and extracted rat tail
collagen (Figure 4.9). However, the bands for the extracted collagen were very faint
suggesting that only small amounts of type I collagen was present following the
extraction process.
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Figure 4.9 Protein bands of the protein ladder, commercial rat tail collagen, and extracted
rat tail collagen (left to right)
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4.5 Wet Spinning Results and Fiber Diameter Characterization
The wet spinning technique was used to synthesize collagen micron fibers using collagen
dispersions of type I bovine collagen in 0.012N He!. Bovine type I collagenJO.012N Hel
was dissolved in 100% wt ethanol to create collagen dispersions for wet spinning fibers .
In this study, 100% wt ethanol was selected as the solvent since it evaporates at a fast

rate, which is ideal for solidification of wet·spun fibers following fiber extrusion in the
coagulation bath. In this study, 2%,5%, and 30% wt type I bovine collagenJO.012N Hel
dispersions in ethanol were prepared for wet spinning collagen fibers. In this study, 17·
gauge and IS·gauge syringe needles were selected for wet spinning collagen fibers.
Extracted type I rat tail collagen was also wet·spun under the same weight percentages in
ethanol but yielded only soft fibers which tended to break easily. Type I bovine collagen
dispersions resulted in stronger wet-spun fibers. Wet-spun fibers synthesized from 30%
wt bovine collagen produced very thick fibers with beading and rough non-uniform

surfaces. The bovine collagen dispersions with 2% and 5% wt in ethanol at a flow rate of
10 mllmin yielded fibers with desirable fiber diameters (Figure 4.10).

a)
b)
c)
d)
Figure 4.10 a) 2% wt type I bovine collagen, 170, b) 5% wt type I bovine collagen, 170,
c) 2% wt type I bovine collagen, ISO, d) 5% wt type I bovine collagen, 180, 4X
magnification
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Some images were taken at 4X magnification of wet-spun fibers produced from
2% and 5% wt bovine collagen dispersions using a Nikon inverting microscope. The
images were imported into Image J software for fiber characterization of wet-spun fibers.
The diameter of wet-spun fibers was determined by taking diameter measurements along
the length of a fiber. Five measurements were taken at five discrete regions along the
length of the fiber (n=25). Each of the five measurements at the different segments of the
fiber was averaged and an overall total average was calculated. The average of
measurements taken from two fibers wet-spun from 2% wt bovine collagen using a 17gauge needle yielded a mean diameter of approximately 2.297 μm (Table 4.2).
A set of measurements was also taken of wet-spun fibers made from 5% wt
bovine collagen using a 17-gauge needle. The mean diameter of 5% wt bovine collagen
wet-spun fibers was approximately 2.536 μm (Table 4.3). The increase in weight
percentage from 2% wt to 5% wt bovine collagen while using the same needle diameter
and flow rate resulted in wet-spun fibers with increased fiber diameters. Therefore, the
parameters established for wet spinning and the 17-gauge needle were suitable for
attaining submicron collagen fibers.
Wet-spun fibers made from 2% and 5% wt bovine collagen using an 18-gauge
needle were also measured. The mean diameter of 2% wt bovine collagen wet-spun
fibers was approximately 1.389 μm (Table 4.4). Furthermore, the mean diameter of 5%
wt bovine collagen fibers using an 18-gauge needle was 1.428 μm. Once again, the flow
rate and the 18-gauge needle were ideal for obtaining sub-micron collagen fibers.
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Table 4.2 2% wt Bovine Collagen Wet-spun Fibers, 17G Needle, (n=50)
Fiber 1: 2% wt
17G Needle

Fiber 2: 2% wt
17G Needle

Measurements

Avg
Measurements
1.5382
1
2
3
4-1
5

Avg
2.4598

1
2
3
4
5

1.271
1.421
1.348_
1.853
1.798

6
7
8
9
10

1.907
2.542
2.01
2.878
2.247

2.3168

6
7
8
9
10

2.247
2.292
2.697
2.697
2.734

2.5334

11
12
13
14
15

3.241
3.866
3.623
3.272
3.423

3.485

11
12
13
14
15

1.798
1.798
1.348
1.798
1.798

1.708

16
17
18
19
20

1.421
2.42
2.842
3.423
3.015

2.6242

16
17
18
19
20

1.798
1.421
1.421
1.798
1.798

1.6472

21
22
23
24
25

2.01
2.542
2.01
2.621
2.247

2.286

21
22
23
24
25

1.853
1.853
2.247
3.178
2.734

2.373

1

2.292
2.292
2.734
2.247 1
2.734

Sub. Avg

Sub. Avg

2.45011m

2.144 gm
Total

2.297 gm
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Table 4.3 5% wt Bovine Collagen Wet-spun Fibers, 17G Needle, (n=25)
1

Fiber 3: 5% wt
17G Needle
Measurements

Avg
2.626

1
2
3
4
5

2.842
2.420
2.734
2.292
2.842

6
7
8
9
10

2.734
2.697
2.697
2.842
2.697

2.7334

11
12
13
14
15

2.292
2.247
2.697
2.247
2.734

2.4434

16
17
18
19
20

2.292
2.247
2.697
3.146
3.623_

2.801

21
22
23
24
25

1.798
1.798
1.853
2.247
2.697

2.0786

Total Avg
2.536 μm
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Table 4.4 2% wt Bovine Collagen Wet-spun Fibers, 18G Needle, (n=25)
Fiber 4: 2% wt I
18G Needle
Measurements
1
2
3
4
5

1.421
1.421
1.005
1.005
1.271

Avg
1.2246

6
7
8
9
10

1.421
1.62
1.421
1.62
2.42

1.7004

11
12
13
14
15

1.421
1.005
1.005
l.348
1.348

1.2254

16
17
18
19
20

1.711
1.920
1.439
1.310
1.620

1.6

21
22
23
24
25

1.271
1.005
l.271
l.421
1.005

1.1946

Total Avg
1.389 μm
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Table 4.5 5% wt Bovine Collagen Wet-spun Fibers, 18G Needle, (n=25)
Fiber 5: 5% wt
18G Needle
Measurements

Avg
2.278

1
2
3
4
5

2.022
2.258
2.346
2.472
2.292

6
7
8
9
10

1.124
1.348
1.589
l.348
1.573

1.3964

11
12
13
14
15

1.573
1.367
1.348
1.348
1.798

1.4868

16
17
18
19
20

1.348
1.348
1.124
1.124
0.899

1.1686

21
22
23
24
25

0.674
0.674
0.899
l.124
0.674

0.809

Total Avg
1.428 gm
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CHAPTER 5
CONCLUSION AND FUTURE WORK

5.1 Summary of DRG Neurite Growth on 2D Collagen Dishes
DRG neurite outgrowth on 2D collagen substrates exhibited an overall linear relationship
over days 1, 5, and 9. Neurite extension on 2D extracted rat tail collagen closely matched
the results observed on 2D commercial rat tail collagen (BD Biosciences). Neurites
appeared to be numerous and extended with ease on both 2D extracted rat tail and
commercial rat tail collagen. The morphology and number of neurites on 2D bovine
collagen had notable differences compared to rat tail collagen. The neurites seemed more
sparse and restricted in extension on bovine collagen coated dishes. This observation may
be due to the higher mechanical properties of bovine collagen, leading to a slight
impedance of neurite outgrowth. The common observation among all 2D collagen
substrates was the increase in standard deviation of neurite outgrowth values from day 1
to day 9. A comparison of growth studies on 2D collagen substrates revealed that axonal
outgrowth was most optimal after 9 days on commercial rat tail type I collagen (BD
Biosciences).

5.2 Summary of DRG Neurite Growth on 3D Collagen Hydrogels
Dorsal root ganglia (DRG) neurite outgrowth in a hydrogel is a desirable approach since
neural tissue is naturally grown in a 3D in vivo environment. Fetal DRG explants plated
within 3D type I collagen hydrogels of varying collagen concentrations (0.6, 0.8, 2.0, and
3.2 mg/ml) exhibited optimal neurite extension in 0.8 mg/ml gels after 9 days of cell
culture. The sandwich method for embedding DRG explants between two hydrogel
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layers proved successful, and the DRGs remained viable by day 9. Standard deviation in
neurite outgrowth values was very small for day 1 but was more significant in days 5 and
9. DRG neurites grew up to an average of 349 μm by day 9, exceeding neurite outgrowth
on 2D substrates. An average of DRG axonal growth between two experiments
confirmed that a collagen gel concentration of 0.8 mg/ml appear to be the most suitable
matrix material for supporting optimal DRG axonal growth over 9 days. Although the
initial assumption was that DRG axonal growth would be more favored on 2D collagen
substrates due to the presence of a rigid surface, the results were contradictory and
indicated that further studies of two and three-dimensional axonal outgrowth on collagen
should be conducted. Furthermore, image analysis of DRG neurites embedded in
hydrogels stained with Vybrant proved to be difficult to visualize since the entire gel was
also stained along with the neurites.

5.3 Summary of Total Protein Assay
The validity of the type I collagen extraction process was assessed by quantifying protein
concentration using BCA total protein assay. Extracted rat tail type I collagen and
commercial rat tail type I collagen (BD Biosciences) were both quantified by colorimetric
detection using the BCA reagent. A comparison of collagen detection using two different
diluents revealed that 0.02M acetic acid was the more appropriate diluent since the
optical density values of both the extracted rat tail type I collagen and commercial rat tail
type I collagen revealed high values when acetic acid was used as the diluent for both
10X and 20X dilutions. Acetic acid most likely yielded higher absorbance values since
the collagen was already in solution with 0.02M acetic acid for both the extracted and
commercial rat tail type I collagen. A best-fit linear regression line constructed from the
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optical density values and corresponding concentrations of the BSA standards resulted in
a correlation of 0.9899 between optical density values and the concentration of the BSA
standards. The calculated concentration of extracted rat tail type I collagen and
commercial rat tail type I collagen at 10X dilution was approximately 0.1054 and
0.09656 mg/ml, respectively. Therefore, the BCA total protein assay indicated that the
concentration of extracted rat tail and commercial rat collagen was approximately 1.05
and 0.966 mg/ml, respectively. These values were significantly lower than the expected
concentrations of extracted rat tail collagen (-4.0 mg/ml) and commercial rat tail collagen
(3.63 mg/ml). Since the absorbance values for the collagen samples were very low, the
results of BCA total protein assay were difficult to interpret for comparing extracted rat
tail to commercial rat tail collagen. The low absorbance values for rat tail type I collagen
in this assay were likely attributed to poor solubility of collagen at certain molecular
weights. The absorbance values from BCA total protein assay more resembled a small
fraction of collagen that was soluble in the diluent. Therefore, other analytical techniques
that confront this solubility issue during collagen quantification are more desirable.

5.4 Summary of SDS Polyacrylamide Gel Electrophoresis (PAGE)
-

Although SDS-PAGE revealed that the extracted rat tail type I collagen was qualitatively
similar to the commercial rat tail type I collagen, the faint bands observed in the extracted
rat tail collagen indicated a very low presence of type I collagen in the end-product of the
extraction. Therefore, the collagen extraction and purification process needs to be further
assessed to ensure that the end-product contains the same amount of type I collagen as
the commercially extracted rat tail collagen from BD Biosciences. An analysis of the gel
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showed doublet bands at 235 kDa and 215 kDa and another pair of doublets at 130 kDa
and 115 kDa, indicating the presence of rat tail type I collagen in both the extracted and
commercial rat tail collagen samples.

5.5 Summary of Wet Spinning Results
The wet spinning technique was used to create collagen micron fibers from collagen
dispersions of bovine type I collagen in 0.012N HCl. Collagen microfilament fibers were
successfully synthesized from 2% and 5% wt bovine collagen/0.012N HCl dispersions in
ethanol. From the 2%, 5%, and 30% wt type I bovine collagen/0.012N HCl dispersions,
the 2% and 5% wt bovine collagen dispersions yielded wet spun collagen fibers that met
the sub-micron diameter range. The increase in weight percentage from 2% wt to 5% wt
bovine collagen while using the same needle diameter and flow rate resulted in wet-spun
fibers with increased fiber diameters. An increase in weight percentage of bovine
collagen dispersions was directly related to the viscosity of the solution. An 18-gauge
needle with a flow rate of 10 ml/min was used to produce collagen fibers as small as
1.398 pm in diameter. According to a previous study, DRGs exhibited optimal axonal
outgrowth along polypropylene fibers as small as 5

μr11

[18]. Although the diameter

range of wet-spun fibers was achieved in this study, the process must be further modified
to yield more consistent diameters throughout the length of the fiber.
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5.5 Future Work

The comparison of DRG axonal outgrowth studies on two and three-dimensional
collagen substrates revealed that further studies are essential to understand the behavior
of neurite extension on rigid and compliant materials. Although the hypothesis was that
DRG axon growth on 2D surfaces would be more favored, the results of this study did
not confirm the hypothesis. The results of wet spinning type I bovine collagen for
creating collagen fibers in the micron scale looks promising. Furthermore, future studies
will be conducted to functionally modify these wet-spun collagen fibers with
biomolecules or neurotrophins to further enhance neurite sprouting and growth along
fibers. The next phase of research is to study DRG axonal outgrowth along wet-spun
fibers and compare their growth to previous studies of outgrowth on 2D and 3D collagen
substrates. A better technique to visualize DRG neurites in 3D collagen hydrogels will
be determined such as using confocal microscopy along with other staining cell markers
or molecular probes such as calcein AM. This study revealed that BCA total protein
assay was not an effective analytical tool for quantifying type I rat tail collagen. In future
studies, other protein assays such as enzyme-linked immunosorbent assay (ELISA) will
be considered as an alternate approach to quantifying collagen.
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